Formation of protein aggregates is the hallmark of neurodegenerative diseases such as Alzheimer's disease, Huntington's disease, and frontotemporal dementia. Many ubiquitin-associated proteins are recruited to protein aggregates, such as sequestosome 1/p62 (p62), parkin, and cereblon (CRBN). However, the roles of these proteins in the regulation of the formation of protein aggregates are not well understood. Here, using cell and animal models, we discover that CRBN directly interacts with p62 and inhibits the formation of protein aggregates induced by mutant huntingtin (Htt-polyQ) and TAR DNAbinding protein 43 (TDP43C) in a p62-dependent manner. Furthermore, we find the suppression of the formation of protein aggregates by CRBN is caused by the decrease of the binding affinity of p62 to ubiquitinated proteins but not by the change of p62 protein level. Our study reveals a novel role of CRBN and the underlying molecular mechanism in the regulation of misfolded proteins in neurodegenerative diseases, which may provide new insights for finding pharmacological targets for these diseases.
Introduction
Neurodegenerative diseases, such as Alzheimer's Disease (AD) and Huntington's disease (HD), are caused by progressive loss of neural cells. According to the Alzheimer's Association's prediction, 11 to 16 million Americans will have AD by 2050 (1) . The Alzheimer's Disease International estimates that there will be 115.4 million people suffering from AD by 2050 worldwide (2) . However, current therapeutic approaches for these diseases are not effective (3) . Therefore, it is necessary to elucidate the molecular mechanisms that cause neurodegenerative diseases and to find the novel therapeutic strategies for their treatment. Although it remains elusive whether protein aggregates are protective or toxic, formation of protein aggregates is the characteristic feature of many neurodegenerative diseases (4) . Formation of protein aggregation is usually recognized as a ubiquitindependent process (5, 6) . Aggregates of ubiquitinated proteins have been discovered in many neurodegenerative diseases, such as mutant SOD1 aggregates in amyotrophic lateral sclerosis (ALS) (7), mutant huntingtin (Htt) aggregates in HD (8) and the mutant ataxin-3 aggregates in spinocerebellar ataxia type 3/ Machado-Joseph disease (SCA3/MJD) (9) . Two protein quality control systems, the Ubiquitin Proteasome System (UPS) and Autophagy Lysosome Pathway (ALP), can degrade the misfolded proteins in mammalian cells (10) . However, in neurodegenerative diseases, due to the gene mutation, the corresponding protein products are prone to form aggregates, which are difficult to be degraded by the UPS and ALP (11) . Therefore, understanding the molecular mechanisms for the formation of protein aggregates and finding new molecules that regulate the formation of protein aggregates are critical for the prevention of neurodegenerative diseases.
As sequestosome 1 (SQSTM1)/p62 (p62) is the common component of protein aggregates in neurodegenerative diseases (12, 13) , the role of p62 in the regulation of the formation of protein aggregates has been studied extensively (14, 15) . The different domains of p62 endow its diverse functions. The N-terminal Phox and Bem1p-1 (PB1) domain of p62 can mediate the interaction between p62 and proteins containing the PB1 domain (16) . The LC3 interaction region (LIR) of p62 interacts with LC3 (17) and the ubiquitin association (UBA) domain binds to polyubiquitinated proteins (18) . The PB1 and UBA domains are essential for p62 to form protein bodies, indicating the importance of p62 in the regulation of protein interactions and binding of polyubiquitin chains in protein aggregates (19, 20) . It has been reported that Bcl-2 regulates the formation of protein aggregates through interacting with the PB1 domain of p62 (20) and casein kinase 2 modulates this process through phosphorylating the UBA domain of p62 (21) . Furthermore, many pathogenic mutations in the UBA domain of p62 are associated with Paget's disease and ALS and these mutations alter the binding affinity of p62 to ubiquitinated proteins (22) . Thus, the interaction between p62 and ubiquitin is critical for the pathogenesis of neurodegenerative diseases.
Cereblon (CRBN) is a substrate receptor of the cullin-4 RING E3 ligase (CRL4) complex (23, 24) , which mediates protein ubiquitination and degradation. It is the primary target of immunomodulatory drugs (IMiDs) (24) such as thalidomide (Thal), lenalidomide (Len), and pomalidomide (Pom) and mediates the anticancer activity of these IMiDs through the UPS (25, 26) . Down-regulation of two transcription factors IKZF1 (Ikaros) and IKZF3 (Aiolos) by CRBN-mediated ubiquitination and subsequent proteasomal degradation in the presence of IMiDs is proved to be the molecular mechanism by which IMiDs inhibit the proliferation of multiple myeloma cells (25, 26) . CRBN also promotes the degradation of nerve cell-associated proteins, such as voltage-gated chloride channel CLC-1 (27) and calciumactivated potassium channel BK Ca (28) . Moreover, the non-degradation role of CRBN in the regulation of its interacting protein has also been discovered (29) . Recent studies show that CRBN can be recruited to aggresome when the proteasome is dysfunctional (30) and also binds to the cytosolic region of the amyloid precursor protein (APP), whose mutations cause AD (31) . However, the roles of CRBN in the regulation of protein aggregates in neurodegenerative diseases and the underlying molecular mechanism remain unknown.
In this study, we find that CRBN is the common component of protein aggregates and regulates the formation of protein aggregates in cell lines, primary fibroblasts, glial cells, and neurons. Furthermore, we discover that CRBN directly interacts with the N-terminus of p62, affects the association between p62 and polyubiquitinated proteins and thus inhibits the formation of protein aggregates of Htt-polyQ and TDP43C in a p62-dependent manner. This work reveals a new regulatory function of CRBN, independent of its role as a substrate receptor of the CRL4 E3 ligase.
Results

CRBN is a common component of protein aggregates
To study the potential role of CRBN in the formation of protein aggregates, we first confirmed the previous finding (30) that CRBN was recruited to aggresome when the proteasome was dysfunctional under our experimental conditions. By transfecting GFP or GFP-CRBN to human embryonic kidney HEK293 cells and treating the cells with proteasome inhibitors, MG132 and bortezomib, we found that CRBN could form aggresome-like particles (Fig. 1A) . We also observed the similar phenomenon in the mouse neuroblastoma N2a cells (Fig. 1B ). To rule out the possible effect of the GFP tag, we transfected Flag-CRBN to HEK293 cells and blocked the proteasome by MG132 and obtained the same result (Fig. 1C) . Furthermore, we observed that CRBN colocalized with p62 and ubiquitin in the protein aggresome in the presence of a proteasome inhibitor MG132 (Fig. 1D) . These results clearly demonstrated that CRBN localized to the aggresome in cells upon proteasome dysfunction.
As the formation of protein aggregates is the major hallmark of neurodegenerative diseases (15), we thought that CRBN might also associate with protein aggregates in neurodegenerative diseases. To test this hypothesis, we employed two protein aggregate models, the Htt-polyQ model (GFP-Htt60Q) and TDP43 model (GFP-TDP43C). Htt60Q contains the N-terminal 208 amino acids of huntingtin and 60 glutamates (32) . TDP43C is the 25-kDa C-terminal fragment of TDP43, which is the pathogenic form in frontotemporal dementia (33, 34) . After expressing these plasmids in HEK293 cells, we found that both the exogenous CRBN and endogenous CRBN were colocalized with the protein aggregates and p62 ( Fig. 1E and F) , which suggests that CRBN is a common component of protein aggregates associated with neurodegenerative diseases.
Considering the binding between CRBN and IMiDs and their roles in the regulation of protein stability, we also investigated the relationship between protein aggregates and IMiDs. The protein aggregates in HEK293 cells resulted from the transfection of GFP-Htt60Q and GFP-TDP43C were not affected by the treatment with three IMiDs, Thal, Len, or Pom (Supplementary Material, Fig. S1 ). This result suggests that CRBN might not play its role as a substrate receptor of the CRL4 E3 ligase in the formation of protein aggregates.
CRBN inhibits the formation of protein aggregates in a p62-dependent manner
Above experiments show that CRBN is the common component of protein aggregates. We then ask whether CRBN regulates the formation of protein aggregates. To do so, we co-transfected GFP-Htt60Q/GFP-TDP43C with mCherry/mCherry-p62/mCherry-CRBN plasmids to HEK293 cells and examined the protein aggregates. We found that more protein aggregates appeared when the cells were overexpressed p62 ( Fig. 2A and B, and Supplementary Material, Fig. S2A ), which is consistent with previous studies (20, 35) . When we further expressed CRBN, protein aggregates were significantly reduced, indicating that CRBN inhibits the formation of protein aggregates ( Fig. 2A and B) . We also used specific sets of siRNAs to knock down endogenous CRBN or p62 (Fig. 2C ) and found more protein aggregates after CRBN knockdown ( Fig. 2D and E) , which is also proved by the filter trap assay (Supplementary Material, Fig. S2B ). Furthermore, we simultaneously knocked down p62 and CRBN in HEK293 cells (Fig. 2F) , and found that the regulation of CRBN on protein aggregates can be obliterated by knockdown of p62 ( Fig. 2G and H) . As the pathogenic TDP43C used here could enhance cellular toxicity but does not cause abnormal CFTR mRNAs splicing as the wild-type TDP43 does (34) 
CRBN interacts with p62
Next, we ask whether CRBN binds to p62 after observing the colocalization of CRBN and p62 by immunofluorescence assay. After overexpressing HA-CRBN and Flag-p62 in HEK293 cells and immunoprecipitating HA followed by immunoblotting, we discovered that CRBN could interact with ectopically expressed p62 ( Fig. 3A ) and endogenous p62 (Fig. 3B ). To narrow down the binding region between CRBN and p62, we constructed several truncated mutants of CRBN and p62 (Fig. 3C ). After transfection, immunoprecipitation, and immunoblotting, we found that both N-terminus and C-terminus of CRBN could interact with p62 ( Fig. 3D and Supplementary Material, Fig. S4A ), whereas only the PB1 domain of p62 (1-102) binds to CRBN (Fig. 3E) . The GSTpulldown assay also shows that CRBN directly interacts with p62 in vitro (Supplementary Material, Fig. S4B ). Taken together, these experiments demonstrate that CRBN directly interacts with the N-terminus of p62.
CRBN suppresses the formation of p62 bodies
The p62 body is a critical feature for the formation of protein aggregates (19, 20) . We wondered if CRBN could regulate the formation of p62 bodies in HEK293 cells. In the mock transfection of GFP, endogenous p62 can clearly form protein bodies. However, overexpression of CRBN reduced the amount of p62 bodies and knockdown of CRBN increased the amount of p62 bodies ( Fig. 4A and B) . Furthermore, we found that knockdown of CRBN increased and overexpression of CRBN decreased the accumulation of p62 in the detergent-insoluble fraction (Supplementary Material, Fig. S5 ). To test whether this effect also holds true in vivo, we cultured primary fibroblast cells from wild-type (WT) or CRBN knockout (KO) mice (Supplementary Material, Fig. S6A ) and then examined the p62 bodies. The results showed that more p62 bodies appeared in CRBN KO primary fibroblasts than in WT primary fibroblasts ( Fig. 4C and  Supplementary Material, Fig. S6B ). We obtained the similar results in the cerebral cortex sections from WT and CRBN KO mice (Fig. 4D) . Because CRBN is the substrate receptor of a CRL4 E3 ligase (23, 24) , which recruits substrates for their ubiquitination and degradation, we asked whether CRBN could regulate the protein level of p62. Surprisingly, there is no significant difference in p62 protein level in the primary fibroblasts of WT and CRBN KO mice (Fig. 4E) . A similar result was also obtained from immunoblotting the whole brain lysate (Fig. 4F) . Since the phosphorylation of p62 at serine 403 (S403) affects the functions of p62 (21), we then immunoblotted for S403-phosphorylated p62 (pS403-p62) and found that CRBN did not regulate its level (Supplementary Material, Fig.  S6C and D) . As p62 was found to be degraded through ALP (19), Figure 2 . CRBN suppresses the formation of protein aggregates in a p62-dependent manner. (A) HEK293 cells were transfected with GFP-Htt60Q or GFP-TDP43C and mCherry, mCherry-p62, or mCherry-CRBN for 24 h. The protein aggregates were examined using immunofluorescence assay. Scale bar: 20 mm. (B) Quantitative data of (A) from three independent experiments were shown as mean 6 SEM. *P < 0.05, **P < 0.01, ***P < 0.001, Student's t test. (C) HEK293 cells were transfected with siNC, sip62, or siCRBN for 48 h, and the cell lysates were subjected to immunoblotting analysis with the indicated antibodies. (D) HEK293 cells were transfected with siNC, sip62, or siCRBN for 24 h, and then transfected with GFP-Htt60Q or GFP-TDP43C for another 24 h. The protein aggregates were examined using immunofluorescence assay 48 h after transfection of siRNAs. Scale bar: 10 mm. (E) Quantitative data of (D) from three independent experiments were shown as mean 6 SEM. *P < 0.05, **P < 0.01, Student's t test. (F) HEK293 cells were transfected with siNC or siCRBN and siNC or sip62 for 48 h, and the cell lysates were subjected to immunoblotting analysis with the indicated antibodies. (G) HEK293 cells were transfected with siNC or siCRBN, along with siNC or sip62 for 24 h, and then transfected with GFP-Htt60Q or GFP-TDP43C for another 24 h. The protein aggregates were examined using immunofluorescence assay 48 h after transfection of siRNAs. Scale bar: 10 mm.
(H) Quantitative data of (G) from three independent experiments were shown as mean 6 SEM. *P < 0.05, **P < 0.01; ns: not significant, Student's t test.
we therefore tested the formation of LC3 particles in HEK293 upon CRBN overexpression. The immunofluorescence and immunoblotting experiments showed no significant difference in the formation of LC3 particles and in the ratio of LC3II/LC3I upon CRBN expression (Supplementary Material, Fig. S6E and F), which suggests that CRBN does not regulate the formation of autophagosome. Taken together, these data demonstrate that CRBN inhibits the formation of p62 bodies in an autophagy-independent manner.
CRBN decreases the binding affinity of p62 to ubiquitinated proteins
The interaction between p62 and ubiquitinated proteins is important for p62 to form protein bodies (19, 20) . We therefore tested the effect of CRBN on the binding affinity of p62 to ubiquitinated proteins since CRBN also interacts with p62. Overexpression of CRBN decreases the binding affinity of p62 to ubiquitinated proteins (Fig. 5A) and knockdown of CRBN increases this affinity (Fig. 5B) . The binding affinity of p62 to ubiquitinated proteins is also increased in the brain lysate of CRBN KO mice compared with that of the WT mice (Fig. 5C ).
Given that the interaction between pathogenic protein HttpolyQ and p62 is mediated by ubiquitin (19, 20) , CRBN may affect the binding affinity of these pathogenic proteins to p62. The results showed that Htt60Q and TDP43C colocalized with ubiquitin in the aggregates (Supplementary Material, Fig. S7 ). We also found that the binding affinity of pathogenic proteins, Htt60Q and TDP43C, to p62 was increased when CRBN was knocked down, and decreased when CRBN was overexpressed (Fig. 5D-G) . Taken together, these data suggest that CRBN can decrease the binding affinity of p62 to ubiquitinated proteins and can affect the interaction between p62 and pathogenic proteins such as Htt60Q and TDP43C.
CRBN-deficient primary cortical neurons are more sensitive to pathogenic protein-induced degeneration
As CRBN inhibits the formation of Htt60Q and TDP43C protein aggregates in HEK293, we further test the role of CRBN on protein aggregates in primary cells. After transfecting GFP-Htt60Q and GFP-TDP43C in primary fibroblasts, glial cells, and cortical neurons from WT and CRBN KO mice, we found that more aggregates appeared in CRBN-deficient primary fibroblasts, glial and cell lysates were subjected to immunoblotting analysis using the GFP, Flag, and GAPDH antibodies. (E) HEK293T cells were transfected with HA-CRBN and Flag, Flag-p62, Flag-p62-1-102, Flag-p62-103-385, or Flag-p62-386-440 for 48 h. The cell lysates were immunoprecipitated using the anti-Flag antibody. The immunoprecipitates and cell lysates were subjected to immunoblotting analysis using the HA, Flag, and GAPDH antibodies. cells, and neurons at 24 h after transfection (Fig. 6A-C) . The neurites in CRBN KO neuronal cells disappeared when the protein aggregates formed, indicating that CRBN protects neurons from degeneration (Fig. 6C) . The data indicate that the regulation of CRBN on the formation of protein aggregates also occurs in primary neural cells.
Discussion
CRBN has both the ubiquitin-dependent and independent roles. As the substrate receptor of the CRL4 E3 ligase, CRBN recruits substrates for ubiquitination and subsequent degradation by the proteasome, which is the ubiquitin-dependent function of CRBN (23, 36) . CRBN also has the ubiquitin-independent function, such as chaperone-like function on promoting the maturation of CD147 and monocarboxylate transporter 1 (37) . In this study, we discovered that CRBN suppressed the formation of aggregates of neurodegenerative diseases-associated proteins, such as Htt60Q and TDP43C, which is also the ubiquitinindependent function of CRBN, as CRBN changes the binding affinity of its interacting partner p62 to ubiquitinated proteins but does not change the protein level of p62 (Figs 4 and 5). Together with previous discovery that the change of interaction between p62 and ubiquitinated proteins affects the formation of protein aggregates (19, 20) , our experiments indicate that CRBN regulates the formation of protein aggregates most probably through the same molecular mechanism (Figs 2 and 5) . Therefore, CRBN may affect the disease pathogenesis not directly through its associated E3 ligase activity but through its binding to p62, thus affecting the affinity between p62 and the ubiquitinated proteins. According to our data, CRBN directly binds to the PB1 domain of p62 but not the UBA domain of p62 (Fig. 3) . This indicates that the regulation of CRBN on binding affinity between p62 and ubiquitinated proteins may be caused by changing the conformation of p62 but not by competing with ubiquitinated proteins to the UBA domain of p62.
IMiDs bind to CRBN and regulate the CRBN interactome, recruiting neo-substrates (new substrates) for their ubiquitination and subsequent degradation (25, 26) . Recently, CRBN has become the attractive molecular target for promoting the ubiquitination and degradation of neo-substrates, such as bromodomaincontaining protein 4, by introducing a reagent which interacts with both CRBN and the substrate desired for degradation (38) . In our experiments, we discovered a novel function of CRBN in the regulation of the aggregation of misfolded proteins, which might provide the new pharmacological target for the treatment of neurodegenerative diseases. Although IMiDs such as Thal, Len, and Pom do not affect the CRBN-mediated inhibition in the formation of protein aggregates (Supplementary Material, Fig. S1 ), it may be possible in the future to discover new chemical compounds that might affect the formation of protein aggregates or degrade protein aggregates.
The role of protein aggregates in neurodegenerative diseases is elusive. It may play the protective role in neurons by sequestering the toxic protein oligomers. It may also be toxic by sequestering the functional proteins like heat shock proteins and inhibiting protein transport through the microtubule system (39, 40) . Our experiments showed that more protein aggregates and degenerated neurites appeared in CRBN KO primary neuronal cells (Fig. 6C) . Hence, our results prove that the inhibition of CRBN on the formation of aggregates of neurodegenerative diseases-associated proteins is protective. Our work also suggests that CRBN may be important in maintaining neural The cells were then harvested and the cell lysates were subjected to immunoprecipitation using the anti-Flag antibody. The immunoprecipitates and cell lysates were subjected to immunoblotting analysis using the indicated antibodies. (B) HEK293T cells were transfected with siNC or siCRBN for 24 h and then transfected with Flag or Flag-p62 for 48 h. The cells were harvested and the cell lysates were immunoprecipitated using anti-Flag antibody. The immunoprecipitates and cell lysates were subjected to immunoblotting analysis with the indicated antibodies. (C) The brain lysates from WT and CRBN KO mice were immunoprecipitated using anti-IgG or antip62 antibody. The immunoprecipitates and cell lysates were subjected to immunoblotting analysis using the indicated antibodies. (D) HEK293 cells were transfected with siNC or siCRBN for 24 h and then co-transfected with GFP or GFP-Htt60Q and Flag-p62 for 48 h. The cells were harvested and the cell lysates were immunoprecipitated using the anti-GFP antibody. The immunoprecipitates and cell lysates were subjected to immunoblotting analysis with the indicated antibodies. (E) HEK293 cells were transfected with siNC or siCRBN for 24 h and then co-transfected with GFP or GFP-TDP43C and Flag-p62 for 48 h. The cells were harvested and the cell lysates were immunoprecipitated using the anti-GFP antibody. The immunoprecipitates and cell lysates were subjected to immunoblotting analysis with the indicated antibodies. (F) HEK293 cells were co-transfected with Flag-p62, GFP or GFP-Htt60Q, and HA or HA-CRBN for 48 h. The cells were harvested and the cell lysates were immunoprecipitated using anti-GFP antibody. The immunoprecipitates and cell lysates were subjected to immunoblotting analysis with the indicated antibodies. (G) HEK293 cells were co-transfected with Flag-p62, GFP or GFP-TDP43C, and HA or HA-CRBN for 48 h. The cells were harvested and the cell lysates were immunoprecipitated using the anti-GFP antibody. The immunoprecipitates and cell lysates were subjected to immunoblotting analysis with the indicated antibodies.
cell survival, which is consistent with the previous findings that CRBN mutation causes mental problems (41) .
In summary, our work established a novel molecular link among CRBN, p62, and protein aggregates (Fig. 7) . Our data suggest that CRBN may be involved in the pathogenesis of neurodegenerative diseases by affecting the formation of protein aggregates. Use of new molecules that connect the CRBN and aggregated proteins for their degradation may be a possible strategy for the treatment of neurodegenerative diseases. Figure 6 . CRBN regulates the formation of pathogenic protein aggregates in primary fibroblasts, glial cells, and neurons. (A) Primary fibroblasts were isolated from postnatal 2 day WT and CRBN KO mice and cultured for 7 days. The primary fibroblasts were transfected with GFP, GFP-Htt60Q, or GFP-TDP43C for 24 h, fixed, and subjected to immunofluorescence assay. Scale bar: 10 mm. Quantitative data from three independent experiments were shown as mean 6 SEM. **P < 0.01, ***P < 0.001, Student's t test (right panels). (B) Primary astrocytes were isolated from postnatal 2-day WT and CRBN KO mice and cultured for 7 days. The primary astrocytes were transfected with GFP, GFP-Htt60Q, or GFP-TDP43C for 24 h, fixed, and subjected to immunofluorescence assay. Scale bar: 20 mm. Quantitative data from three independent experiments were shown as mean 6 SEM. *P < 0.05, **P < 0.01, Student's t test (right panels). (C) Primary cortical neurons were isolated from postnatal 0-2 day WT and CRBN KO mice and cultured for 7 days. The primary neurons were transfected with GFP, GFP-Htt60Q, or GFP-TDP43C for 24 h, fixed, and subjected to immunofluorescence assay. The white arrow showed the degenerate neurites (neurites disappeared when the protein aggregates formed). Scale bar: 20 mm. Quantitative data from three independent experiments were shown as mean 6 SEM. **P < 0.01, ***P < 0.001, Student's t test (right panels).
Materials and Methods
Animals
The CRBN KO mice were kindly provided by Dr. Yong Cang at Zhejing University (China). The mice were housed under conditions at a 12-h light and 12-h dark cycle. PCR genotyping of CRBN mice were carried out with the following primers. CRBN forward: CAGTCAGATGGGTAAGGAGCA, reverse: AAGCAGCTC CGTAATGCTG; GAPDH forward: GGTGAAGGTCGGTGTGAACG, reverse: TTACGGGATGGGTCTGAACG. The WT and CRBN KO mice from the same littermate were used to perform the experiments. All animal procedures were approved by the Institutional Animal Care and Use Committee of Soochow University.
Plasmid constructs
The plasmids of Flag-CRBN, Flag-p62, GFP-Htt60Q, and GFP-TDP43C were described previously (20, (42) (43) (44) (45) . The GFP-p62-1-102, GFP-p62-103-385, GFP-p62-386-440, mCherry-p62, GFP-CRBN, GFP-CRBN-1-338, GFP-CRBN-339-442, mCherry-CRBN, and His 6 -CRBN were generated by standard PCR-subclone methods. PCR products were amplified from Flag-p62/Flag-CRBN, and subsequently inserted into pEGFP-N3, mCherry-C1 and pET-21a vectors. The primers used for the subclone were provided in the Supplementary Material.
Cell culture and transfection
HEK293 cells were grown in Dulbecco's Modified Eagle's Medium (DMEM) (Gibco) containing 10% Fetal Bovine Serum (FBS) (Gibco), 100 units/ml penicillin, and 100 mg/ml streptomycin. Lipofectamine 3000 (Invitrogen) was used to transfect plasmids and RNAiMAX (Invitrogen) was used to transfect siRNAs. All siRNAs and a negative control (siNC: 160818) were purchased from GenePharma (Shanghai, China). The sequences were: sip62: sense: CAUGUCCUACGUGAAGGAUGAUU, antisense: AAU CAUCCUUCACGUAGGACAUG. siCRBN: sense: CCCAGACACUGA AGAUGAAAU, antisense: AUUUCAUCUUCAGUGUCUGGG.
Culture primary fibroblasts
The day 2 neonatal mice were used to culture the primary fibroblasts. Briefly, the mouse head, tail, and limbs were amputated with surgical scissors. The skin was separated from the viscera and put in pre-cold Hank's balanced salt solution. The tissue was cut into $1 mm pieces and digested at 37 C for 20 min using 15 ml 0.25% trypsin solution to obtain the individual fibroblast cells. The cells were centrifuged at 2000 rpm for 5 min and the supernatant was discarded. The cells were then resuspended in DMEM containing 10% FBS, 100 units/ml penicillin, and 100 mg/ml streptomycin and transferred to 24-well plate.
Culture primary astrocytes and cortical neurons
The day 2 neonatal mouse cortical tissues were dissected and meninges were removed. The tissues were digested using 0.25% trypsin solution to obtain individual cells. After centrifuged at 1000 rpm for 5 min, the pellet was resuspended in DMEM containing 10% FBS, 100 units/ml penicillin, and 100 mg/ml streptomycin for culturing astrocytes or neurobasal plating media containing 2% FBS, 2% B27 supplements, and 2 mM L-glutamine for culturing cortical neurons. The cells were plated at 200 000 cells/well on coverslips coated with poly-D-lysine in 24-well plates. Neurobasal culture media containing 2% B27 supplements, and 2 mM L-glutamine were used to replace the neuronal culture media every other day. The specific markers of astrocytes (GFAP, Santa Cruz) and neurons (MAP2, Santa Cruz) were used to visualize cells.
Immunohistochemistry
The method for immunohistochemistry was described previously (46) . Briefly, the WT and CRBN KO mice at 8 weeks of age were perfused with 4% paraformaldehyde in 0.1 M PBS. After perfusion, mouse brains were harvested and treated with 30% sucrose at 4 C overnight. A freezing microtome was used to obtain 20 mm thick mouse cerebral cortex slices. The slices were incubated with anti-rabbit p62 antibody (Sigma) at room temperature for 6 h, and then incubated with rhodamine (red)-conjugated secondary antibody (Invitrogen). At last, the slices were stained with DAPI for 5 min, and observed using Zeiss LSM710 confocal microscope (Germany).
Immunoprecipitation
Cells were lysed with RIPA lysis buffer containing 25 mM TrisHCl (pH 7.4), 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, and fresh protease inhibitor cocktail (Roche). The RIPAinsoluble debris was removed by centrifugation at 12 000 rpm for 30 min at 4 C. The supernatants were subjected to However, loss of CRBN leads to the opposite effect.
immunoprecipitation with rabbit polyclonal anti-FLAG or anti-GFP antibodies, IgG (Beyotime), or mouse monoclonal anti-p62 antibodies (Santa Cruz) coupled to protein G sepharose beads (Roche) overnight at 4 C. The protein G sepharose beads were washed with RIPA lysis buffer for six times and then eluted with 2 Â SDS sample loading buffer for immunoblotting analysis.
In vitro pulldown assay
An aliquot containing GST or GST-tagged proteins expressed in E. coli was incubated with 30 mL of glutathione agarose beads (Pharmacia) for 30 min at 4 C. After washed three times with PBS, the beads were incubated with His 6 -tagged CRBN protein expressed in E. coli for 3 h at 4 C. Then, the beads were washed five times with PBS to remove the nonspecific binding. GST bound proteins were eluted with 2 Â SDS sample loading buffer for immunoblotting analysis. GST tagged proteins were detected using Coomassie staining and His 6 -CRBN was detected using anti-CRBN antibody.
Immunoblotting
Cell lysates or immunoprecipitates were separated by SDS-PAGE and proteins were transferred to PVDF membrane (Millipore). Western blotting was performed according to a previous procedure (47) . The following primary antibodies were used: Flag (Sigma), GFP (Santa Cruz), GAPDH (HuaAn Biotechnology), mouse p62 (Santa Cruz), rabbit p62 (Enzo Life), rabbit S403-phosphorylated p62 (Affinity Biosciences), mouse CRBN (48) (a gift from Dr. Xiu-Bao Chang, Mayo Clinic College of Medicine, USA), and rabbit CRBN (ProteinTech). The secondary antibodies were sheep anti-rabbit IgG-HRP antibodies or antimouse IgG-HRP (Amersham Pharmacia Biotech). Proteins were visualized using Immobilon Western chemiluminescent horseradish peroxidase substrate (Millipore) and the signals were recorded on a ChemiDoc imaging system (Bio-Rad).
Immunofluorescence assay
Cells were washed twice with PBS and fixed with 4% paraformaldehyde for 10 min at room temperature. Cells were penetrated using 0.25% Triton X-100 at room temperature for 5 min, and then blocked using 5% FBS for 1 h. Cells were incubated with related primary antibodies at room temperature for 2-3 h, washed three times with PBST, and then incubated with the corresponding fluorescent secondary antibodies for 1 h. The cellular nuclei were labeled using Hoechst or DAPI (Sigma). The primary antibodies used in this experiment included p62 (Santa Cruz and Enzo Life), Flag (Sigma), and MAP2 (Santa Cruz), and the secondary antibodies were Alexa fluor 594 (red) and Alexa fluor 488 (green) conjugated fluorescent secondary antibodies (Invitrogen). Cells were visualized using an Olympus IX71 inverted optical microscope (Olympus).
Data analysis
Adobe Photoshop 7.0 was used to analyse the densitometry of immunoblots from three independent experiments and the final data were analysed using Origin 6.0 (OriginLab). P-values were calculated using the Student's t test.
Supplementary Material
Supplementary Material is available at HMG online.
